Therapeutic Asset Ratings
136 results matching 1 filter
133,990 assets · 8,802 sponsors · 3,128 indications
Methodology v0.2
Filters
1
Highest Rated
Advanced Phase
Alphabetical
Recently Updated
Asset
Sponsor
Phase
Rating
Capecitabine
HER2-negative Breast Cancer
Kristina A. Fanucci
P4
BB
(68)
EXEMESTANE
HER2-negative Breast Cancer
National Cancer Institute (NCI)
P4
BB
(66)
FULVESTRANT
HER2-negative Breast Cancer
Olema Pharmaceuticals, Inc.
P4
BB
(66)
Irinotecan
HER2-negative Breast Cancer
GI Innovation, Inc.
P4
BB
(66)
(+)-VINCRISTINE
HER2-negative Breast Cancer
GI Innovation, Inc.
P4
BB
(66)
Ribociclib
HER2-negative Breast Cancer
National Cancer Institute (NCI)
P4
BB
(65)
Elacestrant
HER2-negative Breast Cancer
Kristina A. Fanucci
P3
BB
(65)
Arimidex
HER2-negative Breast Cancer
National Cancer Institute (NCI)
P4
BB
(64)
Eloxatin
HER2-negative Breast Cancer
Kristina A. Fanucci
P4
BB
(64)
Everolimus
HER2-negative Breast Cancer
MedSIR
P4
BB
(64)
Inno-206
HER2-negative Breast Cancer
George Washington University
P4
BB
(64)
Letrozole
HER2-negative Breast Cancer
National Cancer Institute (NCI)
P4
BB
(64)
TAMOXIFEN
HER2-negative Breast Cancer
University of Chicago
P4
BB
(64)
Palbociclib
HER2-negative Breast Cancer
Helwan University
P2
BB
(64)
Epirubicin
HER2-negative Breast Cancer
Fudan University
P2/3
BB
(64)
Abemaciclib
HER2-negative Breast Cancer
Jonsson Comprehensive Cancer Center
P4
B
(63)
LEUPROLIDE
HER2-negative Breast Cancer
Olema Pharmaceuticals, Inc.
P4
B
(63)
Zoladex
HER2-negative Breast Cancer
Memorial Sloan Kettering Cancer Center
P4
B
(63)
Carboplatin
HER2-negative Breast Cancer
Fudan University
P3
B
(62)
Vinorelbine
HER2-negative Breast Cancer
Wang Jiayu
P3
B
(62)
CIS-DIAMMINEDICHLOROPLATINUM II
HER2-negative Breast Cancer
Peking University First Hospital
P3
B
(61)
Eribulin
HER2-negative Breast Cancer
Sun Yat-sen University
P2
B
(61)
Cyclophosphamide
HER2-negative Breast Cancer
George Washington University
P3
B
(60)
ERIBULIN MONOMETHANESULFONATE
HER2-negative Breast Cancer
National Cancer Institute (NCI)
P3
B
(60)
Olaparib
HER2-negative Breast Cancer
The First Affiliated Hospital with Nanjing Medical University
P3
B
(60)
Showing 1 to 25 of 136 assets
Previous
Page 1 of 6
Next